These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 284846)

  • 1. High-pressure liquid chromatographic analysis of 3-deazauridine-5'-triphosphate in human cancer cells.
    Plunkett W; Benvenuto JA; Stewart DJ; Loo TL
    Cancer Treat Rep; 1979 Mar; 63(3):415-20. PubMed ID: 284846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid.
    Stewart DJ; Benvenuto JA; Leavens M; Hall SW; Benjamin RS; Plunkett W; McCredie KB; Burgess MA; Loo TL
    Cancer Res; 1979 Oct; 39(10):4119-22. PubMed ID: 476649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography.
    Plunkett W; Chubb S; Barlogie B
    J Chromatogr; 1980 Dec; 221(2):425-30. PubMed ID: 6938519
    [No Abstract]   [Full Text] [Related]  

  • 4. Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells.
    Dahlig-Harley E; Paterson AR; Robins MJ; Cass CE
    Cancer Res; 1984 Jan; 44(1):161-5. PubMed ID: 6580947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
    Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
    Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and disposition of 3-deazauridine in humans.
    Benvenuto JA; Hall SW; Farquhar D; Stewart DJ; Benjamin RS; Loo TL
    Cancer Res; 1979 Feb; 39(2 Pt 1):349-52. PubMed ID: 761206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells.
    Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
    Cancer Res; 1984 Jun; 44(6):2534-9. PubMed ID: 6722792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
    Grant S; Cadman E
    Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia.
    Barlogie B; Plunkett W; Raber M; Latreille J; Keating M; McCredie K
    Cancer Res; 1981 Mar; 41(3):1227-35. PubMed ID: 7459863
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
    Liliemark JO; Plunkett W
    Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
    White JC; Hines LH
    Cancer Res; 1987 Apr; 47(7):1820-4. PubMed ID: 3028615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme pattern-directed chemotherapy: synergistic interaction of 3-deazauridine with D-galactosamine.
    Jackson RC; Williams JC; Weber G
    Cancer Treat Rep; 1976 Jul; 60(7):835-43. PubMed ID: 188552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia.
    Gandhi V; Xu YZ; Estey E
    Clin Cancer Res; 1998 Jul; 4(7):1719-26. PubMed ID: 9676847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of nucleosides and their phosphate esters--1. The acidic nucleosides, 3-deazauridine and 6-azauridine.
    Welch AD; Nemec J; Panahi J
    Int J Biochem; 1984; 16(6):587-91. PubMed ID: 6205910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample preparation and estimation of plasma concentration of 3-deazauridine by high-performance liquid chromatography.
    Lin KT; Momparler RL; Rivard GE
    Ther Drug Monit; 1983; 5(4):491-6. PubMed ID: 6659019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of 3-deazauridine in mice.
    Cysyk RL; Gormley PE; D'Anna ME; Adamson RH
    Drug Metab Dispos; 1978; 6(2):125-32. PubMed ID: 26526
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines.
    Zimm S; Johnson GE; Chabner BA; Poplack DG
    Cancer Res; 1985 Sep; 45(9):4156-61. PubMed ID: 2411397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial and pharmacokinetics of a daily x 5 schedule of 3-deazauridine.
    Creaven PJ; Priore RL; Mittelman A; Bruno S; Henderson ES; Rustum YM; Solomon JK
    Cancer Treat Rep; 1982 Jan; 66(1):81-4. PubMed ID: 7053271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
    Karle JM; Cysyk RL
    Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.